SCHEMBL7792286

SCHEMBL7792286

COC(=O)C(C=O)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31324750 0.80
SCHEMBL20931243 0.77 SMN1; SMN2 (0.43)
SCHEMBL31324711 0.76 SMN1; SMN2 (0.39)
SCHEMBL31324723 0.76 SMN1; SMN2 (0.39)
SCHEMBL7276278 0.76 SMN1; SMN2 (0.39)
SCHEMBL222114 0.74
SCHEMBL9457204 0.74 SMN1; SMN2 (0.39)
SCHEMBL31324730 0.72 SMN1; SMN2 (0.36)
SCHEMBL31648857 0.72 SMN1; SMN2 (0.36)
SCHEMBL31324777 0.72 SMN1; SMN2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104511026-A Modification adenosine receptor agonist nanoprobe, and production method and use thereof UNIV FUDAN 2015-04-15 CN claimed
EP-4285906-A2 AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Epizyme Inc (US) 2023-12-06 EP disclosed
EP-3555070-B1 AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF EPIZYME INC (US) 2023-08-09 EP disclosed
CN-116041346-A Amine-substituted heterocyclic compounds as EHMT2 inhibitors and methods of use thereof EPIZYME股份有限公司 2023-05-02 CN disclosed
CN-110088099-B Amine-substituted heterocyclic compounds as EHMT2 inhibitors and methods of use thereof EPIZYME股份有限公司 2023-01-31 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20220235065-A1 AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Epizyme, Inc. 2022-07-28 US disclosed
US-20200039998-A1 AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Epizyme, Inc. 2020-02-06 US disclosed
EP-3555070-A1 AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Epizyme Inc (US) 2019-10-23 EP disclosed
CN-104511026-B Modify adenosine receptor agonist nano-probe and its preparation method and application 复旦大学 2018-07-24 CN disclosed
EP-2822559-A1 IMIDAZO [1, 2 - B]PYRIDAZINE - BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND USES THEREOF Lexicon Pharmaceuticals, Inc. (US) 2015-01-14 EP disclosed
US-20130245021-A1 IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE OXFORD FINANCE LLC, AS COLLATERAL AGENT 2013-09-19 US disclosed
WO-2013134219-A1 IMIDAZO [1, 2 - B] PYRIDAZINE - BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND USES THEREOF LEXICON PHARMACEUTICALS, INC. (US) 2013-09-12 WO disclosed
US-20070185178-A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists AATRAZENECA AB (SE) 2007-08-09 US disclosed
EP-0679939-B1 Acyl substituted oxonol dyes EASTMAN KODAK CO (US) 2001-11-14 EP disclosed
EP-0572635-B1 COMPOUNDS HAVING A GUANIDINE STRUCTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME CENTRE NAT RECH SCIENT (FR) 1996-12-27 EP disclosed
EP-0679939-A1 Acyl substituted oxonol dyes EASTMAN KODAK COMPANY (US) 1995-11-02 EP disclosed
US-5451494-A Photographic elements containing acyl substituted oxonol dyes EASTMAN KODAK COMPANY (US) 1995-09-19 US disclosed
US-5015554-A Comprising an acid-forming photosensitive compound, an acid-cleavable diacetal and a water insoluble binder; photoresists; plasticizing; flexible films HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-14 US disclosed
EP-0302359-A2 Positive photo-sensitive compositions HOECHST AKTIENGESELLSCHAFT (DE) 1989-02-08 EP disclosed